| No |
SUBJECT |
DATE |
|
19 |
|
2018-10-29 |
|
18 |
|
2015-11-16 |
|
17 |
|
2014-06-14 |
|
16 |
|
2014-06-14 |
|
15 |
Gardiquimod / Loxoribine (RWJ 21757) / R-848 (Resiquimod, S 28463) - TLR7 and TLR8 Ligand
|
2014-04-05 |
|
14 |
Fasudil (HA 1077) Dihydrochloride / Rho Kinase Inhibitor III (Rockout) / Y-27632 - ROCK Inhibitor
|
2014-04-05 |
|
13 |
NSC23766 Hydrochloride
|
2014-04-05 |
|
12 |
|
2014-03-07 |
|
11 |
|
2014-03-07 |
|
10 |
|
2014-02-27 |
|
9 |
|
2014-02-25 |
|
8 |
BEZ235 - NVP-BEZ235 – PI3Ka/g/d Inhibitor / NVP-BEZ235 Hydrochloride - PI3Ka/g/d Inhibitor
PI-103 – PI3K, mTOR and DNA-PK Inhibitor / PI-103 Hydrochloride – PI3K, mTOR and DNA-PK Inhibitor
PIK-75 – PI3Ka Inhibitor VIII
|
2014-01-20 |
|
7 |
Compound 15e Dihydrochloride – PI3Ka Inhibitor / GDC-0941 – PI3Ka/d Inhibitor /
17-b-Hydroxywortmannin (HWT) / IC87114 - PI3Kδ Inhibitor / LY 294002 – PI3K Inhibitor
|
2014-01-20 |
|
6 |
AS 604850 – PI3Kg Inhibitor II / AS041164 – PI3Kg Inhibitor VII / AS-252424 – PI3Kg/CKII Inhibitor
AS-605240 – PI3Kg Inhibitor / Compound 15e – PI3Ka Inhibitor
|
2014-01-20 |
|
5 |
WYE-23 – sub-nanomolar selective / WYE-28 – sub-nanomolar selective / WYE-354 – mTOR Inhibitor
|
2014-01-13 |
